Antidepressants and Suicide Risk: Challenging the Misinformation


In a recent news report, the renowned Danish physician, Peter C. Gøtzsche, challenges the prevailing narrative surrounding antidepressants and their alleged protective effect against suicide. Gøtzsche argues that the common belief, propagated even in medical literature, that antidepressants guard against suicide is not only inaccurate but dangerously misleading.

Complex Relationship Between Antidepressants And Suicide

The conventional wisdom, as found in package inserts for antidepressants, suggests that the risk of suicide may increase at the beginning of treatment, especially for individuals under the age of 25 with psychiatric disorders.

However, Gøtzsche contends that this information oversimplifies the complex relationship between antidepressants and suicidal tendencies.

Gøtzsche points out that the effect of antidepressants does not manifest after a specific number of days but rather develops gradually. Even after the commonly prescribed six-week trial period, the difference in depression symptoms between those on active substances and those on placebos is minimal, leading many critics to question the actual efficacy of these medications in treating depression.

Contrary to popular belief, Gøtzsche emphasizes that suicidal thoughts can emerge at any time, particularly during dose changes, whether increases or decreases. This nuance, he argues, is not adequately addressed by regulatory agencies, such as the Danish Medicines Agency.

The report challenges the notion that the increased risk of suicide diminishes after the age of 25. Gøtzsche cites an FDA analysis from 2006, demonstrating a continuous increase in suicide risk up to the age of 40.

The cornerstone of Gøtzsche’s argument lies in the findings from placebo-controlled trials, revealing that depression medication doubles the risk of suicide and completed suicides in children and young people. A 2019 analysis further indicated that this risk extends to adults, even after discontinuation of the medication.

Gøtzsche accuses the global medical community of perpetuating a narrative that contradicts established research. He conducted a Google search on “suicide and antidepressants” and discovered a systematic pattern of misinformation in the top search results.

Organizations like Psychiatry in the Capital Region were found to claim that antidepressants do not increase the risk of suicide or violence, presenting a stark contrast to the scientifically validated evidence.

Furthermore, Gøtzsche critiques studies and reports that attempt to downplay the risks associated with antidepressants. He scrutinizes a report from the Centre for Suicide Research that, despite acknowledging a 50% increase in the risk of repeated suicide attempts with antidepressant use, later adjusts the analysis in a way that contradicts the initial findings.

The news report highlights the urgent need for accurate and transparent information surrounding antidepressants and their potential risks. Gøtzsche concludes that the systematic misinformation perpetuated by medical professionals poses a severe threat to public health.

The report emphasizes the critical role of medical practitioners in acknowledging the risks associated with antidepressants, especially in vulnerable populations like children and young adults.

As the debate intensifies, Gøtzsche’s perspective challenges the established narrative, calling for a reassessment of how information about antidepressants is communicated to both medical professionals and the general public.

The report underscores the importance of prioritizing transparency and evidence-based practices in mental health discussions, ultimately advocating for a more responsible approach to prescribing antidepressants and managing their associated risks.


— About the Author —

Leave a Reply

Your email address will not be published. Required fields are marked *

Up Next

How a Vegan Diet Could Combat Sleep Apnea, According to Study

In the ongoing quest to combat sleep apnea, researchers may have uncovered a simple yet potentially effective solution: switching to a vegan diet.

A groundbreaking study suggests that adopting a plant-based diet rich in vegetables, fruits, grains, and nuts could significantly reduce the risk of obstructive sleep apnea (OSA), offering hope for the millions of individuals affected by this debilitating condition.

OSA, characterized by the intermittent cessation of breathing during sleep due to airway obstruction, poses a significant health concern for millions of Americans. Beyond the immediate impact on sleep quality, OSA is associated with a heightened risk of various health complications, in

Up Next

“Olive Oil Drug” Shows Promise in Treating Glioblastoma, Early Trial Suggests

In the realm of cancer treatment, a glimmer of hope emerges for patients grappling with the devastating diagnosis of glioblastoma—a fast-growing and aggressive brain tumor. Dubbed the “olive oil drug,” idroxioleic acid, or 2-OHOA, derived from oleic acid, the primary fatty acid in olive oil, has shown promise in an early trial for glioblastoma patients.

Glioblastoma poses a formidable challenge in the medical field, with over 12,000 Americans diagnosed each year and an average survival rate of merely eight months. Despite extensive research efforts, effective treatment options for this deadly cancer have remained elusive.

However, a beacon of optimism shines through as doctors explore the potential of 2-OHOA in combating glioblastoma. The novel drug works by altering the walls of tumor cells, hindering their growth and spread—a crucial mechanism in curb

Up Next

Keto Diets Show Promise in Managing Mental Illnesses, Research Suggests

In recent years, high-fat, low-carb keto diets have garnered attention for their potential role in managing mental illnesses. Clinical trials are underway to explore the diet’s effects on conditions such as bipolar disorder, schizophrenia, depression, anorexia, alcoholism, and PTSD.

Dr. Shebani Sethi, leading research into the diet’s mental health applications at Stanford University, emphasizes that the ketogenic diet is not merely a passing trend but a legitimate medical intervention.

Developed over a century ago for pediatric

Up Next

Breakthrough Study Reveals How Chronic Stress Fuels Cancer Spread

In a groundbreaking study conducted by researchers at Cold Spring Harbor Laboratory (CSHL), a profound connection between chronic stress and the spread of cancer has been unveiled.

Led by former CSHL postdoc Xue-Yan He, along with Adjunct Professor Mikala Egeblad and Professor Linda Van Aelst, the study sheds light on the mechanisms through which stress exacerbates cancer metastasis. Published in Cancer Cell, their findings open new avenues for potential treatment strategies to halt cancer progression before it gains momentum.


Up Next

Fasting-Mimicking Diet Claims to Reverse Aging Signs by 2.5 Years

In the perpetual quest for eternal youth, a recent study published in the journal Nature Communications has unveiled a promising contender: the fasting-mimicking diet (FMD). Researchers report that this innovative eating plan could potentially reduce a person’s biological age by an average of 2.5 years.


Up Next

Breakthrough Misophonia Treatment: Researchers Discuss the Unified Protocol Therapy

Misophonia, a condition characterized by a strong aversive reaction to specific sounds, has long puzzled both patients and clinicians due to its interdisciplinary nature. However, a new therapy known as the Unified Protocol (UP) is gaining traction as a potential Misophonia treatment option.

Developed by psychologists from Duke University, Kibby McMahon, and Clair Cassiello-Robbins, the UP offers a transdiagnostic approach to emotional disorders, including misophonia.

The UP stands out from traditional cognitive behavioral therapy (CBT) approaches by addressing emotional experiences and management across vari

Up Next

Unlocking the Mystery of Chronic Fatigue Syndrome: Exploring Causes, Concerns, and Coping Strategies

In today’s fast-paced society, feeling fatigued has become a common occurrence for many individuals. However, when exhaustion becomes a persistent companion, it may signify underlying health concerns that warrant attention. This report delves into the intricacies of ongoing chronic fatigue, exploring its potential causes, associated concerns, and avenues for coping.

Chronic Fatigue Syndrome (CFS), also referred to as myalgic encephalomyelitis, stands as a complex and enigmatic illness characterized by relentless fatigue. Recent estimates suggest that between 836,000 to 2.5 million Americans grapple with CFS, with a notable fraction experiencing severe debilitation, confining them to bed or their homes at times.